Read before the Surgical Section of the Suffolk District Medical Society, January 2, 1889.

Data from the studies showed that treatment with depemokimab led to a statistically significant reduction in nasal polyp size and nasal obstruction compared to placebo plus standard of care at 52 ...

The main causes of sleep apnea include obesity, blocked nasal passages, and weak throat muscles. However, in Rajesh’s case, it was found that the obstruction in his airway was because of nasal ...

Results demonstrate that depemokimab significantly improves total nasal polyps score and nasal obstruction symptoms while maintaining a safety profile comparable to placebo. Chronic rhinosinusitis ...

By Day 7, 72% of patients reported clear nasal breathing, with the cumulative response rate rising to 86% at Week 2 and 94% at Week 4. Potent and sustained control of nasal symptoms： ...

Total symptom scores, nasal obstruction, and doctor and patient perception of improvement were measured as markers of disease severity. Results: Although not statistically significant, both ...

Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published ...